Key result
Cardiac PET/CT provides comprehensive noninvasive assessment of coronary atherosclerosis and myocardial blood flow in CAD.
Why the study?
Cardiac PET/CT offers a unique opportunity for comprehensive noninvasive evaluation of atherosclerosis and physiologic processes in patients at risk of or with known CAD.
Answers are grounded in this paper and cite their sources.
PET quantification may refine CAD phenotyping; leaves open incremental clinical utility versus other modalities.
Positron emission tomography (PET) is a powerful noninvasive imaging tool for phenotyping patients at risk of or with known coronary artery disease (CAD). One of the key advantages over other imaging modalities is its unique ability to quantify physiologic processes, including myocardial blood flow (in milliliters per minute per gram of myocardium), metabolism, and cardiac receptors, and its high sensitivity for delineating and quantifying molecular targets in vivo using targeted imaging probes. Cardiac PET/CT offers opportunity for a comprehensive noninvasive evaluation of the consequences of atherosclerosis in the coronary arteries and the myocardium.
No takes yet. Share an insight, caveat, or question.
Galazka et al. (2016) conducted a review in Coronary artery disease (CAD). Cardiac PET/CT was evaluated. Cardiac PET/CT enables comprehensive noninvasive evaluation of coronary atherosclerosis and myocardial physiology, including blood flow quantification, in patients with or at risk for CAD.
Synapse has enriched 10 related papers. Consider them for comparative context: